A phrase such as “peptide therapy” can sound like the name of a single treatment. Ask what medicine is actually being discussed. That name is the link between a conversation, a prescription and the information that goes with it.
Work through these words with the proposed product in mind. Each definition ends with a question to carry into the visit. It is fine to ask for the answer in everyday language, even when the person speaking has used the term before.
A name for the medicine
Peptides are chains made from amino acids, which are also the pieces used to build proteins.
The word peptide describes chemistry; by itself, it settles neither safety nor legal status, as of November 3, 2026.
- Ask for the medicine’s name and its form: for example, a shot, tablet or cream. Follow that with a question about its purpose.
- Write the answer as given, then ask what each unfamiliar part means.
The part meant to produce the drug’s effect is called its active ingredient.
A name for an ingredient is only part of the answer. Keep the product and its form beside it in your notes. That gives the next conversation something specific to refer to.
Prescription and assessment
The order that lets a pharmacy dispense a prescription medicine comes from a licensed prescriber.
Under federal law as of November 3, 2026, handing out a prescription drug without the required prescription is a violation.
A consultation is a chance to discuss a concern and the possible response. Do not treat the name of a visit as the answer to whether a medicine fits you. Ask what has to be learned before a decision can be made.
- Ask who will assess your concern and who would write any prescription.
- Ask what remains to be checked if there is no decision during the call.
FDA approval
For drug approvals, the federal agency to know is the Food and Drug Administration (FDA).
Semaglutide is an example of a peptide medicine with FDA-approved uses, as of November 3, 2026. For adults with type 2 diabetes, Ozempic (semaglutide) is approved to help manage blood sugar, with diet and exercise. Wegovy (semaglutide) is used for weight reduction and keeping weight off, with a reduced-calorie diet and more physical activity. The approved uses depend on the product and form; ask which use applies to the one being discussed.
Approval concerns a particular product and its named uses, rather than peptide care as a whole.
- Ask which exact product is proposed and what its approved use is.
- Ask for a written name to look up, rather than relying on a general approval claim.
Compounding and its limits
Compounding replaces a drug company’s finished medicine with one prepared by a pharmacist, a physician or an FDA-registered facility.
Here, a registered facility is a place that has chosen to sign up with FDA to prepare compounded medicines. FDA inspects these facilities, but registration alone does not show that an inspection has happened or that the place or its drugs have FDA approval, as of November 3, 2026.
As of November 3, 2026, a compounded preparation does not carry FDA approval; the agency has not reviewed it for quality, safety or effectiveness before marketing.
FDA describes a role for this preparation when the person has a medical need an approved product cannot fill, or that product is unavailable.
Ask what need is being addressed. A broad claim about “personalized” care leaves that question open. Keep the proposed change separate from the reason offered for it, so both are clear in your notes.
- Ask what is being changed and why it matters for your care.
- Ask which pharmacy will prepare the medicine and which will send it.
Research wording
A bottle marked “for research use only” is being described as a chemical for laboratory work, rather than treatment for a person. In warning letters current as of November 3, 2026, FDA said that website promises to treat illness or change how the body works showed the products were being offered as drugs, despite that label. FDA alleged that selling or shipping those unapproved new drugs across state lines violated federal law.
Those letters concern particular businesses; they are agency allegations rather than court judgments.
When “research use” comes up during a care discussion, ask the speaker to identify the product and explain its status. Leave with words that can be checked.
Ask what the bottle says, what health effect the website promises, and whether the proposed medicine is FDA-approved or compounded. Ask the prescriber to explain the legal basis for that exact product and use, rather than pointing only to a label.
Read the medicine sources